{
    "organizations": [],
    "uuid": "6a8416cf4e12c2272e8f631f8ef591c34db542a7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-zhejiang-xianju-pharmaceutical-see/brief-zhejiang-xianju-pharmaceutical-sees-q1-2018-net-profit-up-120-pct-to-160-pct-idUSL3N1RB27Z",
    "ord_in_thread": 0,
    "title": "Zhejiang Xianju Pharmaceutical sees Q1 2018 net profit up 120 pct to 160 pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 29(Reuters) - Zhejiang Xianju Pharmaceutical Co Ltd\n* Sees Q1 2018 net profit to increase by 120 percent to 160 percent, or to be 35.7 million yuan to 42.2 million yuan\n* Says Q1 2017 net profit was 16.2 million yuan\n* Says that inclusion of new companies and stable increase of main business as the main reasons for the forecast\nSource text in Chinese: goo.gl/hSpqZ1\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-03-29T12:11:00.000+03:00",
    "crawled": "2018-03-30T12:48:07.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "zhejiang",
        "xianju",
        "pharmaceutical",
        "co",
        "ltd",
        "see",
        "q1",
        "net",
        "profit",
        "increase",
        "percent",
        "percent",
        "million",
        "yuan",
        "million",
        "yuan",
        "say",
        "q1",
        "net",
        "profit",
        "million",
        "yuan",
        "say",
        "inclusion",
        "new",
        "company",
        "stable",
        "increase",
        "main",
        "business",
        "main",
        "reason",
        "forecast",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}